中国实用儿科杂志 ›› 2025, Vol. 40 ›› Issue (3): 188-193.DOI: 10.19538/j.ek2025030602

• 指南.标准.共识 • 上一篇    下一篇

过敏性疾病及其靶向治疗儿童疫苗接种专家共识

  

  1. 执 笔:郑 琪
    其他共识制定专家(按姓氏汉语拼音顺序排序):郭 莉(浙江大学医学院附属儿童医院);胡 昱(浙江省疾病预防控制中心);季 钗(浙江大学医学院附属儿童医院);金海丽(浙江省中西医结合医院);卢美萍(浙江大学医学院附属儿童医院)任韵清(浙江大学医学院附属儿童医院);孙金峤 (复旦大学附属儿科医院);吴 磊(浙江大学医学院附属儿童医院);杨旭燕(浙江大学医学院附属第二医院);杨思睿(吉林大学第一医院);张建基 (山东大学齐鲁儿童医院);郑 琪(浙江大学医学院附属儿童医院); 曾华松 (广州市妇女儿童医学中心)
  • 出版日期:2025-03-06 发布日期:2025-04-17
  • 通讯作者: 卢美萍,电子信箱: meipinglu@zju.edu.cn
  • 基金资助:
    浙江省“尖兵”“领雁”研发攻关计划资助项目(2023C03032)

Expert consensus on vaccination of children with allergic diseases and on targeted therapy

  • Online:2025-03-06 Published:2025-04-17

摘要: 儿童过敏性疾病的发病率逐年上升。随着诊疗技术的发展,生物制剂、小分子化合物等靶向药物逐渐应用于过敏性疾病患儿。过敏性疾病患儿由于疾病本身及靶向药物的应用其罹患感染性疾病的风险增加。本共识针对过敏性疾病儿童及其在靶向药物治疗期间疫苗接种相关临床问题进行文献查阅并通过多学科专家讨论,最终形成共识,为儿科临床实践提供参考依据。

关键词: 靶向治疗, 儿童, 过敏性疾病, 生物制剂, 疫苗接种

Abstract: The incidence of allergic diseases in children is increasing year by year. With the development of diagnosis and treatment technology, targeted therapy such as biologics and small molecule compounds is gradually applied to children with allergic diseases. Children with allergic diseases and those treated with targeted therapy are at increased risk of developing infectious diseases. This consensus reviews the literature on vaccination-related clinical issues of children with allergic diseases and those receiving targeted therapy. Through the multidisciplinary expert discussions, the consensus is finally formed, which is aimed to provide a reference for pediatricians in clinical practice.

Key words: targeted therapy, child, allergic disease, biologics, vaccination